Lifeboat Foundation

Read how Congress is pressing the DEA to reclassify marijuana from a Schedule I drug to Schedule III.

Marijuana is currently classified as a Schedule I drug, meaning these are “drugs with no currently accepted medical use and a high potential for abuse.” However, a team of 21 bipartisan congressional leaders from both the Senate and House of Representatives hopes to change that as they recently sent a letter to the United States Drug Enforcement Administration (DEA) pushing them to “promptly remove marijuana from Schedule I of the Controlled Substances Act (CSA)”, noting that almost eight months had passed “since the Department of Health and Human Services (HHS) recommended rescheduling marijuana to Schedule III — and 18 months since President Biden directed HHS and the Department of Justice (DOJ) to begin the process of reviewing marijuana’s scheduling.”

Examples of other Schedule I drugs include heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote, while Schedule III drugs include Tylenol, ketamine, anabolic steroids, and testosterone. Additionally, the penalties between Schedule I and Schedule III drugs also demonstrate stark contrasts, as well.

Continue reading “Bipartisan Effort Demands DEA Action on Marijuana Scheduling” »

From stabilizing qubits (the basic unit of information in a quantum computer) to maintaining the superconducting properties of materials and keeping NASA’s James Webb Space Telescope cool enough to observe the heavens, ultracold refrigeration is essential to the operation of many devices and sensors. For decades, the pulse tube refrigerator (PTR) has been the workhorse device for achieving temperatures as cold as the vacuum of outer space.

These refrigerators cyclically compress (heat) and expand (cool) high pressure helium gas to achieve the “Big Chill,” broadly analogous to the way a household refrigerator uses the transformation of freon from liquid to vapor to remove heat. For more than 40 years, the PTR has proven its reliability, but it is also power-hungry, consuming more electricity than any other component of an ultralow temperature experiment.

02:15 Consciousness as an illusion10:02 How would a belief look in the brain?23:07 Two kinds of dualism29:49 What if you and I see blue differently?38:34 Is…

A scientist at the University of Portsmouth claims to have ‘evidence’ that humanity exists with a simulation. In the 1999 movie The Matrix, the plot centers around the fact that we live in a digital simulation, and scientist Melvin Vopson claims that fact may match the fiction of the popular blockbuster.

Vopson has written extensively on the topic of the possibility that the known universe is a digital facsimile. He has provided articles for The Conversation and authored a book, Reality Reloaded, on the theme.

But while many of the theories posited about the universe being a simulation are in the realm of the abstract, Vopson now claims to have evidence that support his theory. “In physics, there are laws that govern everything that happens in the universe, for example how objects move, how energy flows, and so on. Everything is based on the laws of physics,” the scientist said in 2022, reports Popular Mechanics.

Non-personalized content and ads are influenced by things like the content you’re currently viewing and your location (ad serving is based on general location). Personalized content and ads can also include things like video recommendations, a customized YouTube homepage, and tailored ads based on past activity, like the videos you watch and the things you search for on YouTube. We also use cookies and data to tailor the experience to be age-appropriate, if relevant.

Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time.

Chemotherapy is the treatment of choice before most cancer surgeries, but a study from the Albert Einstein College of Medicine of Yeshiva University in New York, using data from mouse models demonstrated that chemotherapy can paradoxically enhance cancer progression.

Lack of genetic variation is never good for species survival.

A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer’s and other neurodegenerative diseases. The nanomaterial alters the interaction between two key proteins in brain cells—with a potentially powerful therapeutic effect.

The innovative findings, recently published in the journal Advanced Materials, were made possible thanks to a collaboration between University of Wisconsin–Madison scientists and nanomaterial engineers at Northwestern University.

The work centers around altering the interaction between two proteins that are believed to be involved in setting the stage for diseases like Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis, or ALS.